Supplemental Figures for Publication titled "Abrocitinib interferes with the performance of T-SPOT.TB assay for latent tuberculosis reactivation: an in vitro study"
Published: 15 January 2025| Version 1 | DOI: 10.17632/wpzc89k24f.1
Contributor:
Yiting LiDescription
Supplemental Figure 1: (a) Quantitative analysis of CD25 expression in CD4 T cells (n=3). (b) Quantitative analysis of CD69 expression in CD4 T cells (n=3). Statistical analysis was done using one-way ANOVA followed by multiple comparisons. Abro, abrocitinib, TB, tuberculosis. *p < 0.05, **p < 0.01. Supplemental Figure 2: (a) Representative flow cytometry and (b-c) quantitative analysis of CD25 and CD69 expression in CD8 T cells (n=3). Statistical analysis was done using one-way ANOVA followed by multiple comparisons. Abro, abrocitinib, TB, tuberculosis, ns, non-significant.
Files
Categories
Dermatology, Tuberculosis